Baylor University Medical Center

Houston, Texas 77030

0 studies enrolling now · 5 studies all time

What they study most

Advanced Estrogen Receptor Positive HER2- Breast Cancer, Hepatic Encephalopathy, Idiopathic Pulmonary Fibrosis, Acute Fatal Form, Multiple Ground Glass Opacities (GGOs), Ulcerative Colitis and Crohn's Disease

Studies at this site

• Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis — Completed
• A Registry for Patients With Multifocal Ground Glass Opacities (GGOs) — Running, not enrolling
• Entyvio (Vedolizumab) Long Term Safety Study — Completed
• GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer — Stopped early
• Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy — Completed